(Q74776168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

1 reference

1 reference

Lamberg TS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Kivistö KT

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Neuvonen PJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

640-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Pharmacokinetic Interactions with Calcium Channel Antagonists (Part I)1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Pharmacokinetic Interactions with Calcium Channel Antagonists (Part II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Dose of midazolam should be reduced during diltiazem and verapamil treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Diltiazem enhances the effects of triazolam by inhibiting its metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: evaluation of their stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Metabolism and disposition of buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990087-X

10.1016/S0009-9236(98)90087-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663178%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference